Key Takeaways
- Shares of Intel opened 4.7% higher at $101.37 following Tigress Financial’s price target increase from $118 to $145 with a maintained Buy recommendation.
- Ben Reitzes from Melius Research maintained his Buy stance with a $165 target, highlighting the foundry operations as a significant growth catalyst.
- In August, CEO Lip-Bu Tan demonstrated confidence by acquiring approximately $10 million in shares at $95 each.
- A Reuters report suggests SK Hynix is exploring a partnership with Intel for U.S.-based memory chip production, which could enhance foundry revenues.
- The Wall Street consensus stands at Hold across 51 analysts, with a mean price target of $108.49.
Shares of Intel (INTC) experienced a notable 4.7% surge on Wednesday, commencing trading at $101.37 after Tigress Financial elevated its price objective from $118 to $145 while maintaining its Buy recommendation. The semiconductor giant had concluded the previous trading day at $97.14.
This upward movement followed an eventful period for the chipmaker, characterized by numerous analyst revisions and emerging reports of a significant manufacturing partnership.
Ben Reitzes, covering the stock for Melius Research, reinforced his Buy recommendation alongside a $165 price objective. His analysis emphasizes Intel’s foundry operations as central to the investment thesis, with his sum-of-the-parts analysis suggesting the company’s dual business segments could justify approximately $200 per share.
According to Reitzes, Intel’s foundry infrastructureāencompassing fabrication facilities, engineering talent, intellectual property, and advanced packaging technologiesāstands to gain strategic importance amid America’s drive toward semiconductor manufacturing independence.
His outlook envisions a potential separation of Intel’s foundry operations around 2030, which would establish an independent American chip manufacturing entity. The current $165 target incorporates a 15%-20% discount relative to the $200 sum-of-the-parts valuation.
Reitzes highlighted Intel’s anticipated capital expenditure increases for 2027 beyond 2026 levels as evidence of management’s conviction in the company’s forthcoming 14A manufacturing technology.
Year-to-date, Intel shares have surged approximately 163%, significantly outperforming AMD’s 130% gain and the VanEck Semiconductor ETF’s roughly 50% advance.
Executive Demonstrates Conviction with $10 Million Purchase
In August, CEO Lip-Bu Tan acquired 105,263 shares at $95 apiece, deploying nearly $10 million. This transaction brought Tan’s total holdings to approximately 1.31 million shares.
Intel simultaneously raised approximately $20 billion through a stock offering priced at $95 per share, accepting roughly 3.5% dilution to finance its foundry expansion strategy.
Potential SK Hynix Partnership Could Boost Foundry Operations
According to a Reuters report, SK Hynix is pursuing negotiations to either lease facilities or establish a partnership with Intel for memory chip manufacturing on American soil. Should this materialize, the arrangement could utilize capacity at Intel’s delayed Ohio manufacturing complex while capitalizing on AI-fueled memory chip demand.
Neither financial details nor a definitive agreement have been disclosed. South Korean authorities may subject any finalized deal to scrutiny regarding technology security implications.
Wall Street Remains Divided on Outlook
The analyst community shows divergent perspectives. Morgan Stanley increased its price target to $84 while maintaining an equal weight stance. Mizuho reduced its objective to $92 with a neutral rating.
UBS elevated Intel to Buy on September 8. Roth Capital pushed its target to $120. Truist increased its objective to $108 while retaining a Hold rating.
Among 51 analysts tracking the stock, Intel carries a consensus Hold rating with a mean price target of $108.49.
The company delivered Q2 earnings of $0.42 per share in July, surpassing the $0.21 consensus estimate, with revenue reaching $16.13 billion, representing 25.2% year-over-year growth. Management provided Q3 2026 EPS guidance of $0.38.





